Show simple item record

dc.contributor.authorOudin, Madeleine Julie
dc.contributor.authorJonas, Oliver H.
dc.contributor.authorKosciuk, Tatsiana
dc.contributor.authorBroye, Liliane C.
dc.contributor.authorCandido Guido, Bruna
dc.contributor.authorWyckoff, Jeffrey
dc.contributor.authorAsokan, Sreeja B.
dc.contributor.authorWhittaker, Charles A.
dc.contributor.authorMa, Duanduan
dc.contributor.authorCima, Michael J.
dc.contributor.authorWisinski, Kari B.
dc.contributor.authorKeely, Patricia J.
dc.contributor.authorBear, James E.
dc.contributor.authorGertler, Frank
dc.contributor.authorRiquelme, Daisy Noelia
dc.contributor.authorLamar, John
dc.contributor.authorLanger, Robert S
dc.contributor.authorHynes, Richard O
dc.contributor.authorLauffenburger, Douglas A
dc.date.accessioned2016-03-22T20:22:15Z
dc.date.available2016-03-22T20:22:15Z
dc.date.issued2016-01
dc.date.submitted2015-09
dc.identifier.issn2159-8274
dc.identifier.issn2159-8290
dc.identifier.urihttp://hdl.handle.net.ezproxyberklee.flo.org/1721.1/101752
dc.description.abstractFibronectin (FN) is a major component of the tumor microenvironment, but its role in promoting metastasis is incompletely understood. Here we show that FN gradients elicit directional movement of breast cancer cells, in vitro and in vivo. Haptotaxis on FN gradients requires direct interaction between α5β1 integrin and Mena, an actin regulator, and involves increases in focal complex signaling and tumor-cell-mediated extracellular matrix (ECM) remodeling. Compared to Mena, higher levels of the pro-metastatic MenaINV isoform associate with α5, which enables 3D haptotaxis of tumor cells towards the high FN concentrations typically present in perivascular space and in the periphery of breast tumor tissue. MenaINV and FN levels were correlated in two breast cancer cohorts, and high levels of MenaINV were significantly associated with increased tumor recurrence as well as decreased patient survival. Our results identify a novel tumor-cell-intrinsic mechanism that promotes metastasis through ECM remodeling and ECM guided directional migration.en_US
dc.description.sponsorshipLudwig Center for Molecular Oncologyen_US
dc.description.sponsorshipBreast Cancer Research Program (U.S.) (post-doctoral fellowship, W81-XWH-12-1-0031)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (NIH grant U54-CA112967)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (NIH grant R01 CA142833)en_US
dc.description.sponsorshipHoward Hughes Medical Instituteen_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (NIH grant U01 CA143069)en_US
dc.description.sponsorshipKathy and Curt Marble Cancer Research Fund (Koch Institute Frontier Award)en_US
dc.description.sponsorshipProstate Cancer Foundationen_US
dc.description.sponsorshipDavid H. Koch Institute for Integrative Cancer Research at MIT (NCI core grant P30-CA14051)en_US
dc.language.isoen_US
dc.publisherAmerican Association for Cancer Researchen_US
dc.relation.isversionofhttp://dx.doi.org.ezproxyberklee.flo.org/10.1158/2159-8290.CD-15-1183en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourceCancer Discoveryen_US
dc.titleTumor cell-driven extracellular matrix remodeling enables haptotaxis during metastatic progressionen_US
dc.typeArticleen_US
dc.identifier.citationOudin, M. J., O. Jonas, T. Kosciuk, L. C. Broye, B. C. Guido, J. Wyckoff, D. Riquelme, et al. “Tumor Cell-Driven Extracellular Matrix Remodeling Enables Haptotaxis During Metastatic Progression.” Cancer Discovery (January 25, 2016).en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorOudin, Madeleine Julieen_US
dc.contributor.mitauthorJonas, Oliver H.en_US
dc.contributor.mitauthorKosciuk, Tatsianaen_US
dc.contributor.mitauthorBroye, Liliane C.en_US
dc.contributor.mitauthorCandido Guido, Brunaen_US
dc.contributor.mitauthorWyckoff, Jeffreyen_US
dc.contributor.mitauthorRiquelme, Daisyen_US
dc.contributor.mitauthorLamar, John Michaelen_US
dc.contributor.mitauthorWhittaker, Charles A.en_US
dc.contributor.mitauthorMa, Duanduanen_US
dc.contributor.mitauthorLanger, Roberten_US
dc.contributor.mitauthorCima, Michael J.en_US
dc.contributor.mitauthorHynes, Richard O.en_US
dc.contributor.mitauthorLauffenburger, Douglas A.en_US
dc.contributor.mitauthorGertler, Franken_US
dc.relation.journalCancer Discoveryen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsOudin, M. J.; Jonas, O.; Kosciuk, T.; Broye, L. C.; Guido, B. C.; Wyckoff, J.; Riquelme, D.; Lamar, J. M.; Asokan, S. B.; Whittaker, C.; Ma, D.; Langer, R.; Cima, M. J.; Wisinski, K. B.; Hynes, R. O.; Lauffenburger, D. A.; Keely, P. J.; Bear, J. E.; Gertler, F. B.en_US
dc.identifier.orcidhttps://orcid.org/0000-0003-2379-6139
dc.identifier.orcidhttps://orcid.org/0000-0001-6988-4260
dc.identifier.orcidhttps://orcid.org/0000-0003-2512-2007
dc.identifier.orcidhttps://orcid.org/0000-0003-3214-4554
dc.identifier.orcidhttps://orcid.org/0000-0002-3048-7927
dc.identifier.orcidhttps://orcid.org/0000-0001-7603-8396
dc.identifier.orcidhttps://orcid.org/0000-0003-4255-0492
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record